ストックスクリーナーアプリを入手
42.55
2.77%
-1.21
前日終値:
$43.76
開ける：
$43.76
24時間の取引高:
461.06K
Relative Volume:
1.15
時価総額：
$787.26M
収益：
$299.77M
当期純損益:
$364.23M
株価収益率:
2.2728
EPS:
18.7211
ネットキャッシュフロー:
$79.27M
1週間 パフォーマンス:
+9.89%
1か月 パフォーマンス:
+37.66%
6か月 パフォーマンス:
+4.19%
1年 パフォーマンス:
+117.09%
1日の値動き範囲:
$41.57
$43.99
1週間の範囲:
$38.80
$43.99
52週間の値動き範囲:
$18.62
$52.24
Rigel Pharmaceuticals Stock (RIGL) Company Profile
名前
Rigel Pharmaceuticals
セクター
電話
650-624-1100
住所
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Compare RIGL vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
42.55 | 787.26M | 299.77M | 364.23M | 79.27M | 18.72 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-05 | アップグレード | Jefferies | Hold → Buy |
| 2023-04-03 | 再開されました | Piper Sandler | Neutral |
| 2022-06-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-06-08 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | 開始されました | B. Riley Securities | Neutral |
| 2020-11-09 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-11-15 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-09-26 | 再開されました | JP Morgan | Overweight |
| 2019-03-01 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-08-27 | 開始されました | Citigroup | Buy |
| 2018-05-02 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 再開されました | Piper Jaffray | Overweight |
| 2017-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-11-06 | 再開されました | H.C. Wainwright | Buy |
| 2017-03-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-31 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-30 | 繰り返されました | Piper Jaffray | Overweight |
| 2016-07-13 | 開始されました | H.C. Wainwright | Buy |
| 2016-06-13 | 開始されました | Piper Jaffray | Overweight |
| 2016-04-22 | アップグレード | JP Morgan | Neutral → Overweight |
| 2013-04-08 | 繰り返されました | Stifel | Buy |
| 2012-11-29 | 開始されました | UBS | Neutral |
| 2012-11-06 | 繰り返されました | Oppenheimer | Outperform |
| 2012-03-26 | 開始されました | Canaccord Genuity | Hold |
| 2010-12-10 | ダウングレード | MP Advisors | Outperform → Market Perform |
すべてを表示
Rigel Pharmaceuticals (RIGL) 最新ニュース
(RIGL) Risk Channels and Responsive Allocation - Stock Traders Daily
Form 4 Rigel Pharmaceuticals Inc For: 10 July By Investing.com - Investing.com South Africa
Rigel Pharmaceuticals (RIGL) CMO receives 24,400-share RSU equity award with 4-year vesting - Stock Titan
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - AOL.com
Rigel Pharmaceuticals (RIGL) Investor update Summary - Quartr
Rigel Pharmaceuticals (RIGL) Q1 2026 earnings summary - Quartr
Rigel Pharmaceuticals (RIGL) Corporate presentation Summary - Quartr
Rigel Pharmaceuticals (RIGL) Proxy filing Summary - Quartr
Rigel Pharmaceuticals (RIGL) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Rigel Pharmaceuticals, Inc. Announces Inducem - Moomoo
Rigel Pharmaceuticals, Inc. (RIGL) Latest Stock News & Headlines - Yahoo Finance
RIGL Stock Jumps 15%, Short Interest Surges To Record High – Why Is Retail Eyeing A Further 40% Upside? - Stocktwits
Rigel awards new hires 13,375 RSUs under its inducement plan - Stock Titan
RI2 Forecast — Price Target — Prediction for 2027 - TradingView
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Sahm
Rigel appoints Alison L Hannah as chief medical officer - MSN
Rigel Pharmaceuticals, Inc. Files 8-K With SEC: Corporate Details, Stock Info, and Compliance Updates - Minichart
Alison Hannah joins Rigel (NASDAQ: RIGL) as new EVP and Chief Medical Officer - Stock Titan
Rigel Pharmaceuticals Appoints Dr. Alison L. Hannah as CMO (RIGL) - GuruFocus
Rigel Pharmaceuticals Appoints Alison L. Hannah as Chief Medical Officer - citybiz
Press Release: Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer - Moomoo
Rigel board member Alison Hannah steps in as chief medical officer - Stock Titan
(RIGL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
RIGL Q1 2026 Earnings: EPS Misses Estimates, Revenue Not Disclosed, Stock Edges HigherRetail Earnings Report - dars.gov.et
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) added to Russell Microcap Value Benchmark Index - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS: RIGL) added to Russell 2000 Value Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – BX:RIGL - TradingView
Rigel Pharmaceuticals, Inc.(NasdaqGS:RIGL) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to EBIT forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
RIGL Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Price to sales forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to revenue forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
Price to earnings forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Price to earnings forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
A40EFY Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Rigel Pharmaceuticals, Inc. – BOATS:RIGL - TradingView
Price to book forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Enterprise value to EBITDA forward of Rigel Pharmaceuticals, Inc. – NASDAQ:RIGL - TradingView
Rigel Pharmaceuticals Inc (RIGL) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Rigel Pharmaceuticals, Inc. Actuals & Estimates (DUS:RI2) - TradingView
Rigel Pharmaceuticals (RIGL) Short Interest & Short Float | Updated Jun 2026 $RIGL - MarketBeat
Form 4 Rigel Pharmaceuticals Inc For: 24 June By Investing.com - Investing.com Nigeria
Rigel Pharmaceuticals director Ali-Jackson Kamil sells $87,500 in stock By Investing.com - Investing.com South Africa
Rigel Pharmaceuticals director Ali-Jackson Kamil sells $87,500 in stock - Investing.com
Rigel Pharmaceuticals (RIGL) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):